Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia

The improvement in outcomes of adult patients with acute lymphoblastic leukemia (ALL) has been modest, with the exception of Philadelphia chromosome-positive disease, despite advances in supportive care and stem cell transplantation. The recent approvals of novel agents, including the bispecific T-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Uy, Natalie, Nadeau, Michelle, Stahl, Maximilian, Zeidan, Amer M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908210/
https://www.ncbi.nlm.nih.gov/pubmed/29713210
http://dx.doi.org/10.2147/JBM.S136575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908210/
https://www.ncbi.nlm.nih.gov/pubmed/29713210
http://dx.doi.org/10.2147/JBM.S136575

Ejemplares similares